About MS Research Australia

“Our mission is to accelerate Australian MS research toward the prevention, better treatments and a cure for MS.”

MS Research Australia is the largest not-for-profit organisation dedicated to funding and coordinating MS research in Australia, as part of the worldwide effort to unravel the complexity of MS.  The primary mission is to accelerate research towards the prevention, better treatments and, ultimately, a cure for MS.

To accomplish this since establishment in 2004, MS Research Australia has invested nearly $32 million into major collaborative research platforms, and investigator led research projects.

MS Research Australia is committed to developing and exploring research initiatives and collaborations, both within the MS research community and across different disease fields and disciplines. We believe this will provide the ability to galvanise and convene the best researchers from around the country and globe and dedicate them to a common unmet need, a world free from MS.

MS Research Australia is a small team of dedicated individuals responsible for all aspects of the operations, ensuring overheads are low so that more of the fundraised dollar can be directed straight to the best MS research projects. MS Research Australia was awarded 2015 Charity of the Year and 2016 Outstanding Achievement Award in the Australian Charity Awards.

Medicines and Healthcare Product Industry Policy Statement

Milestones in the MS Research Australia journey

Blood test developed by MS Research Australia-supported Macquarie University researchers that can distinguish between relapsing and progressive forms of MS.
MS Research Australia completed a survey of the Australian MS community, including people affected by MS, health professionals and researchers, to determine the priorities for MS research.
MS Research Australia awarded ‘Most Effective Creative Campaign’ and best ‘Special Event – under $5m revenue’ for its Kiss Goodbye to MS fundraising campaign by the Fundraising Institute of Australia (FIA).
MS Research Australia awarded Outstanding achievement award in the Australian Charity Awards.
MS Research Australia was awarded Charity of the Year in the Australian Charity Awards.
MS Research Australia funded researchers at NeuRa, NSW, who developed a clinical intervention aiming to reduce the risk of falls in people with MS and are now testing the intervention in a state-wide clinical trial.
Researchers funded by MS Research Australia in NSW published important findings that help to explain how chemicals released by immune cells can contribute to myelin damage, revealing new pathways for potential treatments.
MS Research Australia and JDRF Australia joined forces to provide an innovative fellowship investigating the genetic overlap between multiple sclerosis (MS) and type 1 diabetes (T1D).
University of Queensland researchers published new evidence for involvement of the Epstein Barr Virus in MS.
45 brains have been donated to the MS Research Australia Brain Bank and the Australian Brain Bank Network around Australia since 2008, allowing new research into MS using gold standard technology.
Researchers from the Sydney Children’s Hospital, NSW found that antibodies could differentiate among children with different types of demyelinating disease. As a result a new clinical tool was developed to guide treatment decisions to help prevent blindness and ongoing disease.
In 2011 and 2013, an international consortium of researchers including the ANZgene MS Genetics Platform made substantial breakthroughs in identifying 110 genes associated with susceptibility to MS. In 2006, only a handful of genes were known.
The vitamin D MS Prevention Trial (PrevANZ), the largest of its type in the world, started recruiting participants across Australia and New Zealand, bringing together evidence on the role of vitamin D in MS.
Researchers from Monash University discovered that blocking a protein involved in nerve fibre breakdown may preserve brain tissue in MS.
The Australian MS Longitudinal Study surveyed almost 2,900 people with MS to determine their needs, building a significant track record of making a tangible difference in service planning and advocacy for people with MS.
Researchers funded by MS Research Australia at the University of Adelaide made a significant breakthrough in finding new ways to control the immune system in MS.
The Economic Impact of MS report identified that 50% of the economic impact of MS in Australia is due to reduced employment for people with MS and their families.
MS Research Australia awarded the first ever international Fellowship dedicated to MS research in collaboration with the MS Society in the United Kingdom, to strengthen worldwide collaboration on MS research.
The Australian New Zealand MS Genetics Consortium (ANZgene) established with funding support and coordination from MS Research Australia. In 2009 ANZgene researchers completed one of the first whole genome screening projects identifying 2 new genetic sites that increase the risk of developing MS.
The Ausimmune Study published findings describing a latitude gradient in Australia for prevalence of the earlies signs of MS (a first demyelinating event). This landmark study provided the foundation for future work into the role of vitamin D and sunlight in MS.
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search